SCHEMBL2564607

SCHEMBL2564607

Fc1cccnc1C1CCC(Cl)(c2ccc3c(c2)CNCc2nncn2-3)CC1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 2/20 0.35
CYP11B2 P19099 2/20 0.32
CYP11B1 P15538 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2559684 0.90 AVPR1A (0.35) AVPR1ACYP11B2
SCHEMBL2543415 0.90 AVPR1A (0.34) AVPR1ACYP11B2CYP11B1
SCHEMBL2566668 0.89 AVPR1A (0.33) AVPR1ACYP11B2CYP11B1
SCHEMBL2564920 0.88 AVPR1A (0.35) AVPR1ACYP11B2
SCHEMBL2563306 0.88 AVPR1A (0.35) AVPR1A
SCHEMBL2472214 0.86 AVPR1A (0.32) AVPR1ACYP11B2CYP11B1
SCHEMBL14844442 0.86 AVPR1A (0.35) AVPR1ACYP11B2CYP11B1
SCHEMBL2567021 0.85 AVPR1A (0.31) AVPR1A
SCHEMBL2567189 0.85 AVPR1A (0.38) AVPR1ACYP11B2
SCHEMBL2563008 0.85 AVPR1A (0.36) AVPR1ACYP11B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560975-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-27 EP claimed
WO-2011131596-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-27 WO claimed
EP-2560975-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-27 EP disclosed
WO-2011131596-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-27 WO disclosed